Show simple item record

dc.contributor.authorGómez Ayala, Jaime Alberto
dc.contributor.authorMeléndez Flórez, Héctor
dc.contributor.authorHernández Sarmiento, Carlos Julio
dc.contributor.authorCacua Gamboa, Paula Catalina
dc.contributor.authorCastillo Meza, María Gabriela
dc.contributor.authorMantilla Giraldo, Sofía
dc.contributor.authorRodríguez Blanco, Carlos Andrés
dc.coverage.spatialBucaramanga (Santander, Colombia)spa
dc.coverage.temporal2021spa
dc.date.accessioned2023-06-29T21:29:59Z
dc.date.available2023-06-29T21:29:59Z
dc.date.issued2021-11
dc.identifier.issnISSN 2344-7079spa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/20382
dc.description.abstractLa coinfección bacteriana en pacientes con enfermedad por COVID-19 es un tema de relevancia ante la práctica actual de terapia antibiótica empírica, por lo tanto es importante conocer y caracterizar a los patógenos más prevalentes para determinar la eficacia en su uso en la práctica diaria.spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.relation.ispartofseriesGeneración Creativa : Encuentro de Semilleros de Investigación UNABspa
dc.relation.urihttp://hdl.handle.net/20.500.12749/20335spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.sourceGómez, J. A., et al. (2021). Coinfección bacteriana en pacientes hospitalizados con Covid-19. Recuperado de: http://hdl.handle.net/20.500.12749/20382.spa
dc.titleCoinfección bacteriana en pacientes hospitalizados con Covid-19spa
dc.typeConferenceeng
dc.title.translatedBacterial coinfection in hospitalized patients with Covid-19spa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.programPregrado Medicinaspa
dc.type.driverinfo:eu-repo/semantics/conferenceProceedingsspa
dc.type.localMemoria de eventosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_f744
dc.subject.keywordsHealth sciencesspa
dc.subject.keywordsMedicinespa
dc.subject.keywordsCovid-19spa
dc.subject.keywordsInvestigationspa
dc.subject.keywordsSARS-CoV-2spa
dc.subject.keywordsBacterial coinfectionspa
dc.subject.keywordsAntibioticsspa
dc.subject.keywordsEmpirical therapyspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.relation.references[1] Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A, et al. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Health. 2021;10:100694.spa
dc.relation.references[2] WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. 2021 [citado 5 de abril de 2021]. Disponible en: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020spa
dc.relation.references[3] COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. 2021 [citado 3 de abril de 2021]. Disponible en: https://coronavirus.jhu.edu/map.htmlspa
dc.relation.references[4] Situacion covid-19 colombia [Internet]. [citado 5 de abril de 2021]. Disponible en: https://sig.sispro.gov.co/SituacionCovid/spa
dc.relation.references[5] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond Engl. 2020;395(10223):507-13.spa
dc.relation.references[6] Karami Z, Knoop BT, Dofferhoff ASM, Blaauw MJT, Janssen NA, Apeldoorn M van, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis. 1 de febrero de 2021;53(2):102-10.spa
dc.relation.references[7] Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. enero de 2021;27(1):83-8.spa
dc.relation.references[8] Critical Care [Internet]. COVID-19 Treatment Guidelines. [citado 13 de abril de 2021]. Disponible en: https://www.covid19treatmentguidelines.nih.gov/critical-care/spa
dc.relation.references[9] Butler CC, Dorward J, Yu L-M, Gbinigie O, Hayward G, Saville BR, et al. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. The Lancet. 20 de marzo de 2021;397(10279):1063-74.spa
dc.relation.references[10] Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 26 de mayo de 2020;323(20):2085-6.spa
dc.relation.references[11] Karaba SM, Jones G, Helsel T, Smith LL, Avery R, Dzintars K, et al. Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study. Open Forum Infect Dis [Internet]. 1 de enero de 2021 [citado 19 de abril de 2021];8(ofaa578). Disponible en: https://doi.org/10.1093/ofid/ofaa578spa
dc.relation.referencesHughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. octubre de 2020;26(10):1395-9spa
dc.contributor.cvlacGómez Ayala, Jaime Alberto [0000971731]spa
dc.contributor.cvlacMeléndez Flórez, Héctor Julio [0000320609]spa
dc.contributor.orcidMeléndez Flórez, Héctor Julio [0000-0003-1791-8099]spa
dc.subject.lembCiencias de la saludspa
dc.subject.lembMedicinaspa
dc.subject.lembCovid-19spa
dc.subject.lembInvestigaciónspa
dc.subject.lembInvestigationspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.description.abstractenglishBacterial coinfection in patients with COVID-19 disease is a relevant issue in view of the current practice of empirical antibiotic therapy, therefore it is important to know and characterize the most prevalent pathogens to determine the efficacy in its use in daily practice.spa
dc.subject.proposalSARS-CoV-2spa
dc.subject.proposalCoinfección bacterianaspa
dc.subject.proposalAntibióticosspa
dc.subject.proposalTerapia empíricaspa
dc.type.redcolhttp://purl.org/redcol/resource_type/EC_AC
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.publisher.deparmentSistema de Investigación SIUNABspa
dc.contributor.researchgroupSemilleros de Investigación UNABspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.description.learningmodalityModalidad Presencialspa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 2.5 Colombia